A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has hit its primary endpoint, setting ...

Formation Bio, the AI-native pharmaceutical company revolutionizing drug development, today announced the appointment of four world-class leaders to its senior team: Louis Brenner, MD, as Chief ...

Biotech entrepreneurship must run in the blood for the Langers.   | Renowned biotech veteran Robert Langer is the executive ...

Percept Corporation, a pioneer in advanced visual perception technology, AI and systems, announces that Anthony Principi has ...

T.Rx Capital was co-founded by Michael Langer, former Pear Therapeutics CEO Corey McMann and Eli Lilly veteran Kwesi Frimpong ...

In this week’s edition of InnovationRx, we look at risks of new vaccine restrictions, virtual clinical trials at the Mayo ...

Starton has been issued multiple U.S. patents covering the continuous delivery of lenalidomide and other immunomodulatory ...

U.S. stocks experienced a modest pullback from their record highs as a strong August retail sales report tempered hopes of a ...

The ascendance of vaccine critic Robert F. Kennedy Jr. as the top health official is creating an environment where promising ...

European Commission President Ursula von der Leyen is set to face two separate no-confidence votes at the EU Parliament in early October, Politico reported on Tuesday, citing an internal email from ...

Well, sorry but…you can’t exactly call them “finished” with 30%–31% and another 10% not responding negatively to the government’s measures, which means they’re still within reach of returning to the ...